483 filings
Page 14 of 25
S-8
evfzjg3o6pea153
7 Jan 11
Registration of securities for employees
12:00am
UPLOAD
tzv76o17iqu21f mpsx
5 Jan 11
Letter from SEC
12:00am
8-K
vmzn 4dh1oq4hnx
7 Dec 10
Other Events
12:00am
CORRESP
oew4dx
1 Dec 10
Correspondence with SEC
12:00am
8-K
jyyp ntxtfqhore
9 Nov 10
Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
12:00am
CORRESP
btcfuyb0c2m1h xg65
29 Oct 10
Correspondence with SEC
12:00am
424B3
u82pyr mc2
26 Oct 10
Prospectus supplement
12:00am
8-K
oj2yqrz60ps05tp
20 Oct 10
Termination of a Material Definitive Agreement
12:00am
8-K
cp8rb0l
12 Oct 10
Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
12:00am
8-K
9ml4yltr yo8ppmtp
7 Sep 10
Alexza Pharmaceuticals to Present at Upcoming Healthcare Conferences
12:00am
CT ORDER
4d7fn5x
1 Sep 10
Confidential treatment order
12:00am
CORRESP
iy526iwp1lc0tao8cvw8
1 Sep 10
Correspondence with SEC
12:00am
8-K
1reyti
26 Aug 10
Other Events
12:00am
CORRESP
z66xcl7d08iom8kx
23 Aug 10
Correspondence with SEC
12:00am
UPLOAD
5kcmyfz
12 Aug 10
Letter from SEC
12:00am
424B5
217c809q8h
5 Aug 10
Prospectus supplement for primary offering
12:00am
8-K
0ui s0qfgeh
5 Aug 10
Entry into a Material Definitive Agreement
12:00am